2021
DOI: 10.3389/fimmu.2021.720811
|View full text |Cite
|
Sign up to set email alerts
|

Is the Immunopeptidome Getting Darker?: A Commentary on the Discussion around Mishto et al., 2019

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
17
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 52 publications
0
17
0
Order By: Relevance
“…42 Genetic correlations were tested for 228 phenotypes with publicly available GWAS summary statistics and 596 traits from the UK Biobank study 43 using LD Hub. 44 In addition, polygenic risk scores 45 were constructed in our sample to explore polygenic heterogeneity across diagnostic subtypes and comorbidities (eMethods in the Supplement).…”
Section: Snp Heritability and Genetic Correlation With Other Traitsmentioning
confidence: 99%
“…42 Genetic correlations were tested for 228 phenotypes with publicly available GWAS summary statistics and 596 traits from the UK Biobank study 43 using LD Hub. 44 In addition, polygenic risk scores 45 were constructed in our sample to explore polygenic heterogeneity across diagnostic subtypes and comorbidities (eMethods in the Supplement).…”
Section: Snp Heritability and Genetic Correlation With Other Traitsmentioning
confidence: 99%
“…33 Specifically, we observed overlaps in predictions of ADHD and ASD as well as BD, MDD, and SCZ, thereby highlighting the known overlaps in preassessment predictors such as earlier diagnoses, genetics, and family history between the disorders. 34,35 Combining high-dimensional genetic data with clinical records increased prediction accuracy by 2% to 11% in our study. However, the overall low decrease in accuracy for each data set shows that the different data modalities have a high overlap in predictive information.…”
Section: Discussionmentioning
confidence: 55%
“…Despite this seminal evidence of the immunological relevance of spliced peptides in HLA‐I immunopeptidomes, their frequency is still a controversial issue. After the publication of the first method for the identification of cis ‐spliced peptides in HLA‐I immunopeptidomes (Liepe et al., 2016 ), other groups published alternative methods and obtained contrasting results about their frequency (Admon, 2021 ; Faridi et al., 2021 ; Mishto, 2020 ; Purcell, 2021 ). Two recent studies re‐analysed the list of cis ‐spliced peptides, which we previously identified in HLA‐I spliced immunopeptidomes using Spliced Peptide Identifier (SPI) and SPI‐delta methods (Liepe et al., 2016 , 2019 ), by using PEAKS X software.…”
Section: Introductionmentioning
confidence: 99%